Ribon Therapeutics Raises $65 Million to Advance Pipeline of Novel Therapeutics Targeting Cellular Stress Pathways for Cancer
January 4, 2019
January 2019
Dr. Vishva Dixit joins The Column Group as Science Partner
The Column Group announced the recruitment of Dr. Vishva Dixit to the firm’s renowned group of Science Partners. Dr. Dixit is Vice President of Physiological Chemistry at Genentech. He is a member of the National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences and a Foreign Member, European
Dr. Vishva Dixit joins The Column Group as Science Partner Read More »
